LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal oral SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It’s in a class of androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033 is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability and patient acceptance due to tissue-selective mechanism of action and an oral route of administration.
Bulking
LGD has shown the most ability of any SARM to put on size that could be considered a bulk. This will, of course, be dependent upon the diet used.
LGD seems to shine with this method. . Ran in conjunction with other SARMS, like cardarine (GW-501516), will only increase the likelihood of a stronger recomp.
LGD can be used to cut as well.
LGD-4033 Research may suggest benefits such as:
- Effects similar to anabolics with size and strength
- Excellent for recomping
- Healing properties
- Prevents muscle wasting
Reviews
There are no reviews yet.